---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-23-008697"
form_type: "8-K"
ticker: "ODYY"
cik: "0001626644"
company_name: "Odyssey Health, Inc."
filed_at: "2023-12-07T23:59:59+00:00"
generated_at: "2026-06-07T16:12:11.424132+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Odyssey Health shareholders approve asset sale of neurological drug therapies to Oragenics

## Summary
- Approved asset purchase agreement of neurological drug therapies and technologies to Oragenics, Inc.
- Vote: 45,032,700 for, 333,249 against, 48,943 abstaining on the asset purchase agreement.
- Approved adjournment proposal: 44,826,263 for, 255,690 against, 332,939 abstaining.
- Special meeting held on December 7, 2023; results filed via 8-K Item 5.07.

## SEC filing metadata
- accession: 0001683168-23-008697
- form_type: 8-K
- ticker: ODYY
- cik: 0001626644
- company_name: Odyssey Health, Inc.
- filed_at: 2023-12-07T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1626644/000168316823008697/0001683168-23-008697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1626644/000168316823008697/odyssey_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-23-008697
- JSON: https://secwatch.observer/filing/0001683168-23-008697.json
- Plain text: https://secwatch.observer/filing/0001683168-23-008697.txt

## Key facts
- Shareholder Votes
  Odyssey Health, Inc. shareholders approved Approval of the asset purchase agreement of its neurological drug therapies and technologies to Oragenics, Inc. (reported as Oragenics in context? Actually the text says "Odyssey Health, Inc. formerly known as Odyssey Group International, Inc. (“Odyssey”) held its Special Meeting of Stockholders. At at the 2023-12-07 meeting.
  - Proposal: merger approval
  - Outcome: passed
  - Meeting: 2023-12-07
  source text: (1) approved the asset purchase agreement of its neurological drug therapies and technologies to Oragenics, Inc.;
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316823008697/0001683168-23-008697-index.htm
- Shareholder Votes
  Odyssey Health, Inc. shareholders approved Approval of adjournment or postponement of the Special Meeting, if necessary at the 2023-12-07 meeting.
  - Outcome: passed
  - Meeting: 2023-12-07
  source text: (2) approved the adjournment or postponement of the Special Meeting, if necessary.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1626644/000168316823008697/0001683168-23-008697-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.